The Technical Analyst
Select Language :
Enzo Biochem Inc [ENZ]

Exchange: New York Stock Exchange Sector: Healthcare Industry: Diagnostics & Research

Enzo Biochem Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Enzo Biochem Inc is listed at the NYSE Exchange

3.23% $2.24

America/New_York / 27 mar 2023 @ 16:00


Enzo Biochem Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 111.24 mill
EPS: 0
P/E: 0
Earnings Date: Jun 07, 2023
SharesOutstanding: 49.66 mill
Avg Daily Volume: 0.792 mill
RATING 2023-03-27
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/211/222/223/224/221/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE 11.79
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE 0 | industry: PE 110.51
DISCOUNTED CASH FLOW VALUE
$2.68
(19.85%) $0.445
Date: 2023-03-28
Expected Trading Range (DAY)

$ 2.15 - 2.33

( +/- 4.11%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-02-13 Walters Ian B. Buy 75 188 Common Stock, $0.01 Par Value
2023-02-13 Wolf James G. Buy 750 Short Put Option (obligation to buy)
2023-02-13 Wolf James G. Buy 750 Short Put Option (obligation to buy)
2023-02-13 Wolf James G. Buy 324 Short Put Option (obligation to buy)
2023-02-13 Wolf James G. Buy 324 Long Call Option (right to buy)
INSIDER POWER
93.57
Last 100 transactions
Buy: 6 523 953 | Sell: 452 030

Forecast: 16:00 - $2.24

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.24
Forecast 2: 16:00 - $2.24
Forecast 3: 16:00 - $2.24
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.24 (3.23% )
Volume 0.266 mill
Avg. Vol. 0.792 mill
% of Avg. Vol 33.57 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Enzo Biochem Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Enzo Biochem Inc

RSI

Intraday RSI14 chart for Enzo Biochem Inc

Last 10 Buy & Sell Signals For ENZ

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Enzo Biochem Inc

ENZ

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Farmingdale, New York.

Last 10 Buy Signals

Date Signal @
SNI.OLMar 28 - 07:29NOK328.00
CAKEUSDMar 28 - 07:43$3.58
CAKEUSDMar 28 - 07:43$3.58
DNB.OLMar 28 - 07:29NOK182.55
YGGUSDMar 28 - 07:42$0.247
TKOUSDMar 28 - 07:42$0.330
NEARUSDMar 28 - 07:42$1.842
LSG.OLMar 28 - 07:28NOK50.25
AVAUSDMar 28 - 07:42$0.576
SCHA.OLMar 28 - 07:28NOK186.00

Stock Peers

Company Price Change
ENZ2.243.23%
UPH1.390-8.55%
SQZ0.6497.40%
VAPO0.590-3.39%
ANVS18.850.27%
AMAM9.11-1.94%
SONX1.8803.30%
SNDA10.22-1.64%
CCM1.260-7.35%
RFL1.650-1.20%
IVC0.6600.00%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.